Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
beta erythropoietin
DRUG
2 trials
Sponsors
PETHEMA Foundation
, Thammasat University
Conditions
Acute Renal Failure
Myelodysplastic Syndrome
Phase 2
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Terminated
NCT00495547
PETHEMA Foundation
Myelodysplastic Syndrome
Start: 2009-02-28
End: 2011-06-30
Updated: 2014-04-07
Phase 3
Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
NCT01066351
Thammasat University
Acute Renal Failure
Start: 2010-01-31
End: 2011-06-30
Target: 200
Updated: 2010-02-10
Related Papers
Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial.
2013-07-05
40 citations